PCS2021 – Pharma Crystallization Summit

Category : PCS2021

Potentials and Technologies to Increase Success Rate of Polymorph Screening

Moderator: Dr. Alfred Lee, Merck

Overcoming Industrial Challenges in Implementation of Crystallization Technologies

Moderator: Dr. Kevin Girard, Pfizer

Realizing Regulatory Challenges in Applying Crystallization Technologies

Moderator: Dr. Christopher Burcham, Eli Lilly and Company

Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264): A Solid-State Chemistry Perspective

Dr. Alfred Lee, Merck Research Laboratories

What Solid Form Should I Choose?

Ann Newman, Seventh Street Development Group

Understanding and Controlling the API Form/Powder Property Risks in Drug Substance and Product Processes

Dr. Shawn Yin, Bristol Myers Squibb

Absolute Structure Determination of API Molecules by MicroED analysis of Cocrystals formed based on Cocrystal Propensity Prediction Calculations

Drs. Chandler Greenwell (XtalPi), Harsh Shah (J-Star), and Jessica Bruhn (NIS)

Examples of Particle Engineering to Improve Patient Outcomes and Product Manufacturing

Dr. Christopher Burcham, Eli Lilly and Company

Crystal Habit Modifications and Spherical Crystallization Design in Solution

Prof. Junbo Gong, Tianjin University

Challenges and Opportunities in Optimizing Mechanical Properties of Drugs by Incorporating Excipients

Prof. Calvin Changquan Sun, University of Minnesota